[Featured Stock] iCure Rises 12% Ahead of Launching Patch-Type Dementia Treatment

[Asia Economy Reporter Minji Lee] IQure is showing an upward trend following news that it will launch the dementia treatment drug Donepezil patch next month.

At 9:14 a.m. on the 1st, IQure was trading at 11,850 won, up 10.23% from the previous trading day. On the same day, IQure surged to 12,350 won during intraday trading.

IQure developed the world's first Donepezil patch. It is expected that sales will increase significantly due to reduced side effects compared to Donepezil pills and ease of use. According to the industry, the domestic Donepezil market size reaches 230 billion won.